chr6-109462738-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014797.3(ZBTB24):​c.*3113T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.518 in 152,006 control chromosomes in the GnomAD database, including 21,448 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.52 ( 21447 hom., cov: 32)
Exomes 𝑓: 0.50 ( 1 hom. )

Consequence

ZBTB24
NM_014797.3 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.563

Publications

50 publications found
Variant links:
Genes affected
ZBTB24 (HGNC:21143): (zinc finger and BTB domain containing 24) Predicted to enable DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to act upstream of or within hematopoietic progenitor cell differentiation. Predicted to be located in nucleus. Implicated in immunodeficiency-centromeric instability-facial anomalies syndrome 2. [provided by Alliance of Genome Resources, Apr 2022]
MICAL1 (HGNC:20619): (microtubule associated monooxygenase, calponin and LIM domain containing 1) This gene encodes an enzyme that oxidizes methionine residues on actin, thereby promoting depolymerization of actin filaments. This protein interacts with and regulates signalling by NEDD9/CAS-L (neural precursor cell expressed, developmentally down-regulated 9). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
MICAL1 Gene-Disease associations (from GenCC):
  • epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.698 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZBTB24NM_014797.3 linkc.*3113T>C 3_prime_UTR_variant Exon 7 of 7 ENST00000230122.4 NP_055612.2
MICAL1NM_001286613.2 linkc.14+2926T>C intron_variant Intron 1 of 24 NP_001273542.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZBTB24ENST00000230122.4 linkc.*3113T>C 3_prime_UTR_variant Exon 7 of 7 1 NM_014797.3 ENSP00000230122.4

Frequencies

GnomAD3 genomes
AF:
0.518
AC:
78609
AN:
151882
Hom.:
21407
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.705
Gnomad AMI
AF:
0.360
Gnomad AMR
AF:
0.506
Gnomad ASJ
AF:
0.513
Gnomad EAS
AF:
0.515
Gnomad SAS
AF:
0.534
Gnomad FIN
AF:
0.475
Gnomad MID
AF:
0.519
Gnomad NFE
AF:
0.415
Gnomad OTH
AF:
0.492
GnomAD4 exome
AF:
0.500
AC:
3
AN:
6
Hom.:
1
Cov.:
0
AF XY:
0.500
AC XY:
3
AN XY:
6
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.500
AC:
3
AN:
6
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.518
AC:
78712
AN:
152000
Hom.:
21447
Cov.:
32
AF XY:
0.519
AC XY:
38593
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.705
AC:
29218
AN:
41460
American (AMR)
AF:
0.506
AC:
7731
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.513
AC:
1778
AN:
3468
East Asian (EAS)
AF:
0.516
AC:
2662
AN:
5158
South Asian (SAS)
AF:
0.534
AC:
2573
AN:
4816
European-Finnish (FIN)
AF:
0.475
AC:
5008
AN:
10544
Middle Eastern (MID)
AF:
0.524
AC:
154
AN:
294
European-Non Finnish (NFE)
AF:
0.415
AC:
28222
AN:
67962
Other (OTH)
AF:
0.492
AC:
1038
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1849
3698
5547
7396
9245
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
686
1372
2058
2744
3430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.450
Hom.:
54622
Bravo
AF:
0.526
Asia WGS
AF:
0.549
AC:
1908
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
5.9
DANN
Benign
0.34
PhyloP100
0.56
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1046943; hg19: chr6-109783941; API